Respiratory Syncytial Virus Infection
📧 Sign up to get email alerts when something new happens for Respiratory Syncytial Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-12-31Clinical Trial Update: Safety and Immunogenicity Study of SCB-1019T in Children [Phase 1]
A Phase 1 safety and immunogenicity trial of SCB-1019T for respiratory syncytial virus infection in children has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-10-28Clinical Trial Update: Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV) [Phase 1]
A Phase 1 safety study of GS-5806 for respiratory syncytial virus infection has been withdrawn.